Btai investors have opportunity to lead bioxcel therapeutics, inc. securities fraud lawsuit

Los angeles , aug. 25, 2023 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against bioxcel therapeutics, inc. ("bioxcel" or the "company") (nasdaq: btai ). class period: december 15, 2021 – june 28, 2023 lead plaintiff deadline: september 5, 2023 if you wish to serve as lead plaintiff of the bioxcel lawsuit, you can submit your contact information at www.glancylaw.com/cases/bioxcel-therapeutics-inc/.
BTAI Ratings Summary
BTAI Quant Ranking